Cosmeceutical Critique

Update on argan oil



Although clinical research data on argan oil are limited, its traditional uses and inclusion in novel cosmetic products suggest that further study is warranted. Randomized controlled trials are needed to elucidate cutaneous benefits, if any, from this rare botanical.

1. J Pharm Pharmacol. 2010 Dec;62(12):1669-75.

2. Altern Med Rev. 2011 Sep;16(3):275-9.

3. J Ethnopharmacol. 1999 Oct;67(1):7-14.

4. Pharmacol Res. 2006 Jul;54(1):1-5.

5. Nutr Rev. 2012 May;70(5):266-79.

6. Eur J Lipid Sci Technol. 2014 Oct;116(10):1316-21.

7. Ann Nutr Metab. 2005 May-Jun;49(3):196-201.

8. Nutr Metab Cardiovasc Dis. 2005 Oct;15(5):352-60.

9. Evid Based Complement Alternat Med. 2006 Sep;3(3):317-27.

10. Cancer Invest. 2006 Oct;24(6):588-92.

11. Cancer Detect Prev. 2007;31(1):64-9.

12. “Liquid Gold in Morocco,” by Amy Larocca, The New York Times, Nov. 18, 2007.

13. Phytomedicine. 2010 Feb;17(2):157-60.

14. J Control Release. 1995;37(3):299-306.

15. Thermochimica Acta. 1997 Jun;293:77-85.

16. Prostaglandins Leukot Essent Fatty Acids. 1995 Jun;52(6):387-91.

17. Int J Cosmet Sci. 1996 Feb;18(1):1-12.

18. Crit Rev Food Sci Nutr. 2010 May;50(5):473-7.

19. Eur J Cancer Prev. 2003 Feb;12(1):67-75.

20. Fitoterapia. 2008 Jul;79(5):337-44.

21. Am J Clin Nutr. 2001 Dec;74(6):714-22.

22. J Cosmet Dermatol. 2007;6(2):113-8.

23. Int J Nanomedicine. 2014 Aug 11;9:3855-64.

24. Clin Interv Aging. 2015 Jan 30;10:339-49.

25. Prz Menopauzalny. 2014 Oct;13(5):280-8.

26. Skin Res Technol. 2013;19:356-7.

27. Inflamm Allergy Drug Targets. 2014;13(3):168-76.

28. Nat Prod Commun. 2010 Nov;5(11):1799-802.

29. J Cosmet Sci. 2014 Mar-Apr;65(2):81-7.

Dr. Baumann is the CEO of Baumann Cosmetic & Research Institute in Miami. She founded the Cosmetic Dermatology Center at the University of Miami in 1997. She is the author of “Cosmetic Dermatology: Principles and Practice” (New York: McGraw Hill, 2002), and a book for consumers, “The Skin Type Solution,” (New York: Bantam Dell, 2006). Her latest book, “Cosmeceuticals and Cosmetic Ingredients” (McGraw Hill) was published in November 2014. Dr. Baumann has received funding for clinical grants from Allergan, Aveeno, Avon Products, Evolus, Galderma, GlaxoSmithKline, Kythera, Mary Kay, Medicis Pharmaceuticals, Neutrogena, Philosophy, Topix Pharmaceuticals, and Unilever. She also develops and owns the Baumann Skin Type Solution skin typing solutions and related products.

Next Article: